New myeloablative therapy offers hope for kids with neuroblastomaSurvival gains seen with busulphan and melphalan treatment Gardasil HPV vaccine approved for rectal cancer preventionHPV infection strongly associated with anal cancer. Memorial University School of Pharmacy to award its first PhD Mohamed Mahmoud's research involved new drug delivery system capable of providing more constant, sustained delivery of treatment for cancer. Ovarian tumour gene profile revealed Overexpression of certain proteins may guide chemotherapy Robot negates need for thrombosis prophylaxis Venous thromboembolism rates low after endometrial cancer surgery, suggesting heparin may be unnecessary Cetuximab fails in treating advanced cervical cancer Benefit in tumours with squamous cell histology not ruled out Fertility-sparing procedure safe in cervical cancer Canadian data support trachelectomy use in younger women Unintended tumour morcellation proves deadly Users of minimally invasive technique ‘hovering on the brink of safety’ Bladder cancer referrals blocked? Few Canadians getting neoadjuvant management, study shows Intermittent ADT as effective as continuous Intermittent androgen deprivation therapy (ADT) may be just as effective as continuous ADT in men with PSA recurrence after radical therapy for prostate cancer, according to a new Canadian study. First Previous 52 53 54 55 56 Next Last
